Exact Sciences (EXAS) announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (ABT) at the special meeting of stockholders. Subject to the satisfaction or waiver of the remaining conditions to closing, the transaction is expected to close before the end of the second calendar quarter of 2026.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Exact Sciences Faces Rising Operational Risk and Strategic Constraints Amid Pending Abbott Merger
- Soros boosts stakes in Microsoft, Electronic Arts, Amazon
- Exact Sciences reports Q4 EPS (45c) vs (27c) last year
- Exact Sciences Faces Shareholder Lawsuits Over Abbott Merger
- Exact Sciences ‘applauds’ passage of MCED legislation